2025/02/28 by Zubin Austin · 1 voice
Health Professions · Medicine · Nursing · #Foundation (evidence) #Health Policy Implementation Science #Interprofessional Education and Collaboration #Medical education #Medicine #Mental Health and Patient Involvement #Nursing
paper · doi:10.1093/ijpp/riaf008
openalex publication_date 2025/02/28 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29
Globally, the shift toward more interprofessional and collaborative models of health care delivery is well entrenched [1]. Tools such as expanding scope of practice are used by governments to create more flexible health care delivery and decision-making options and to circumvent strangleholds based on profession-specific activities [2]. In the context of medication therapy management, the proliferation of legislatively enabled ‘prescribing’ roles and responsibilities for professions such as pharmacy, nursing, chiropody, and midwifery illustrates the ways in which health policy makers view decentralizing of authorities traditionally reserved for medical practitioners as a powerful way to enhance efficiency and effectiveness of health services work [2, 3]. Within pharmacy, the move to ‘independent prescribing’ by pharmacists in countries such as the UK and Canada raises important issues and some concerns regarding quality and safety. While there is little doubt that pharmacists have the knowledge and skills to prescribe medications in specific circumstances, real-world limitations (including lack of access to relevant laboratory testing data, or the absence of a central, secure, electronic health record accessible by all health care professionals) can undermine pharmacists’ best efforts in providing best possible patient care [4]. Limitations such as these increase the likelihood that ‘independent’ prescribing may actually increase the risk of creating health care silos in which—literally—the right hand and the left hand are unaware of what each are doing. For example, a patient who wants an antibiotic for a viral infection may be told ‘no’ by a medical practitioner (with access to laboratory testing data) in the morning but be told ‘yes’ by a pharmacist (who does not have access to these data or a shared medical record indicating the medical practitioner’s rationale) in the afternoon. Even when there is an interprofessional shared medical record (as is increasingly common), the risk of profession-specific silos in decision-making can be significant [4]. Such silos are not limited to interprofessional situations: intra-professional collaboration amongst individuals who share the same professional designation can also be similarly isolated (e.g. between hospital-based and community-based pharmacists) [4].